ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
127.375 IP-LS
Project title
A Novel Encapsulated Cell Therapy for Sanfilippo Syndrome Type IIIA

Texts for this project
 GermanFrenchItalianEnglish
Key words
-
-
-
Anzeigen
Abstract
-
-
-
Anzeigen

Inserted texts


CategoryText
Key words
(English)
Life sciences, Medtech
Abstract
(English)
Release Tx (RTx) develops the Myo-P® platform for intracerebral enzyme therapy in genetic CNS disorders. RTx seeks funding to complete a preclinical proof of concept using its technology to deliver continuous Heparan Sulfamidase (SGSH) in a mouse model of MPS IIIA (Sanfilippo syndrome type IIIA).